Advancing the development of vaccines through recombinant technology

In this interview, News-Medical talks to Dr. Amy Sheng, the head of CRO at Sino Biological, about
current developments in the field of vaccine development through recombinant techniques.

Related Keywords

United States ,Alex Smith ,Mark Zipkin ,Amy Shenghead ,Amy Sheng ,Sino Biological Inc ,Georgia Institute Of Technology ,Sino Biological Us Inc ,Manufacturers Association Of America Ph ,Sponsored Content ,Sino Biological Inc May ,Sino Biological ,Pharmaceutical Research ,Manufacturers Association ,Caprico Biotechnologies ,Cell Biology ,Georgia Institute ,Technology ,Antibodies ,Ntibody ,Ntigen ,Fell ,Cholera ,Hronic ,Covid 19 ,Na ,Efficacy ,Fever ,Gastrointestinal Tract ,Enetic ,Genetic Information ,Glycosylation ,Healthcare ,Immune Response ,Immune System ,Immunity ,Immunization ,Infectious Diseases ,Nterleukin ,Ntracellular ,Medicine ,Muscle ,Utation ,Pandemic ,Athogen ,Protein ,Research ,Skin ,Typhoid ,Typhoid Fever ,Vaccine ,Virus ,